These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 976204)

  • 21. A comparison between effects of estradiol valerate and low dose ethinyl estradiol on haemostasis parameters.
    Lindberg UB; Crona N; Stigendal L; Teger-Nilsson AC; Silfverstolpe G
    Thromb Haemost; 1989 Feb; 61(1):65-9. PubMed ID: 2526387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced beta adrenergic responsiveness in rats treated with estrogenic agents.
    Black DJ; Fregly MJ; Thrasher TN; Moreland AF
    J Pharmacol Exp Ther; 1976 May; 197(2):362-70. PubMed ID: 1271285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of administration and withdrawal of oral contraceptive pills on serum lipids and lipoproteins.
    Arora S; Arora RC; Garg RK; Agarwal N; Nautiyal A
    Indian J Physiol Pharmacol; 1988; 32(1):67-71. PubMed ID: 3169963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Excretion of ethinyloestradiol sulfonate in the human milk (author's transl)].
    Klinger G; Claussen C; Schröder S
    Zentralbl Gynakol; 1981; 103(2):91-5. PubMed ID: 7234211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of tumor promoting contraceptive steroids on growth and drug metabolizing enzymes in rat liver.
    Ochs H; Düsterberg B; Günzel P; Schulte-Hermann R
    Cancer Res; 1986 Mar; 46(3):1224-32. PubMed ID: 3943094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogenic activities of estradiol enantate and ethinylestradiol compared at a clinical level.
    Moguilevsky JA; Wiemeyer JC; Sagasta CL; Leiderman S
    Arzneimittelforschung; 1986 Nov; 36(11):1671-4. PubMed ID: 3101711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on thyroid hormones and androgen parameters: conventional vs. extended-cycle use.
    Sänger N; Stahlberg S; Manthey T; Mittmann K; Mellinger U; Lange E; Kuhl H; Wiegratz I
    Contraception; 2008 Jun; 77(6):420-5. PubMed ID: 18477491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum lysozyme activity in patients with lung carcinoma subjected to radiotherapy.
    Prokopowicz J; Kemona H; Wysocka J; Kiluk S
    Neoplasma; 1985; 32(5):605-11. PubMed ID: 4069293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum lysozyme activity in patients with Hodgkin's disease undergoing chemotherapy.
    Prokopowicz J; Kemona H; Wysocka J; Kiluk S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(3):338-47. PubMed ID: 2444507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experimental therapy of acute radiation sickness with ethinylestradiol. II. Radioprotective effect of ethinylestradiol on hemopoietic system (author's transl)].
    Lu RS; Li ZW; Xu CX; Zhao TF; Wang RQ; Liu SH; Yang FT; Pi GH; Huang SL; Niu HS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1980 Sep; 2(3):156-61. PubMed ID: 6451314
    [No Abstract]   [Full Text] [Related]  

  • 31. [Dynamics of some indices of immune defense and physical fitness in school children].
    Nasolodin VV; Voronin SM; Zaĭtsev ON; Zaĭtseva IP
    Gig Sanit; 2001; (2):54-6. PubMed ID: 11494494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ontogeny of androgen receptor and disruption of its mRNA expression by exogenous estrogens during morphogenesis of the genital tubercle.
    Agras K; Willingham E; Liu B; Baskin LS
    J Urol; 2006 Oct; 176(4 Pt 2):1883-8. PubMed ID: 16945680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes in serum lysozyme activity in terminal states caused by blood loss].
    Anan'eva SK
    Biull Eksp Biol Med; 1975 Nov; 80(11):32-4. PubMed ID: 1218255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Complement and lysozyme levels in the blood of children with viral hepatitis].
    Mikhaĭlova ZM; Safarov SS
    Pediatriia; 1986 May; (5):19-23. PubMed ID: 3737324
    [No Abstract]   [Full Text] [Related]  

  • 35. [Dynamics of complement, its components and serum lysozyme activity in respiratory viral and enteroviral infections in children].
    Mikhaĭlova ZM; Sokolova AF; Derechinskaia ShL
    Vopr Okhr Materin Det; 1967 Mar; 12(5):9-14. PubMed ID: 5613311
    [No Abstract]   [Full Text] [Related]  

  • 36. [Proteolytic activity of the serum at 3.5 pH and serum lysozyme in systemic connective tissue diseases].
    Miceková D; Stefanovic J; Zitnan D; Cebecauer L; Lulovicová M
    Bratisl Lek Listy; 1983; 79(4):442-9. PubMed ID: 6344961
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum prognostic indicators in experimental Bacteroides peritonitis.
    Sharbaugh RJ; Rambo WM
    Arch Surg; 1975 Sep; 110(9):1146-9. PubMed ID: 1156168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of high altitude hypoxia and decreased external temperature on the levels of complement, lysozyme and beta-D-glucuronidase in the blood, spleen and liver of rats].
    Ferencíková J; Zajdlíková E; Horáková E
    Fysiatr Revmatol Vestn; 1981 Oct; 59(5):267-75. PubMed ID: 7198080
    [No Abstract]   [Full Text] [Related]  

  • 39. [Serum complement: physiologic and pathologic variations].
    Nouv Presse Med; 1977 Oct; 6(35):3177-8. PubMed ID: 928046
    [No Abstract]   [Full Text] [Related]  

  • 40. [Determination of dog complement components by use of human serum reagents].
    Mashkov AV
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Sep; 42(9):138. PubMed ID: 5872294
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.